Home > Healthcare > Medical Devices > Diagnostic Devices > Newborn Screening Market

Newborn Screening Market Share

Report ID: GMI8223
Published Date: Feb 2024
Report Format: PDF

Download Free Sample

Newborn Screening Market Share

Leading industry players are developing innovative technologies and solutions to expand their portfolio. They are collaborating with healthcare providers to enhance screening accuracy and accessibility. These players are also introducing advanced methods and expanding their global reach to ensure early detection and intervention for newborns worldwide.

Newborn Screening Market Companies

Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
GE Healthcare
Masimo Corporation
Medtronic plc
Natus Medical Incorporated
PerkinElmer, Inc.
Thermo Fisher Scientific Inc.
Trivitron Healthcare
Waters Corporation

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Newborn screening market size was USD 950.5 million in 2023 and is expected to register 7.7% CAGR from 2024-2032 owing to the rising incidence of genetic and metabolic diseases and growing burden of congenital disorders worldwide.

Newborn screening industry from the instruments segment is expected to register 7.8% CAGR from 2024-2032 due to clinics increasingly employing sophisticated instruments for newborn screening to detect metabolic and genetic disorders early.

North America newborn screening industry is expected to record over USD 837 million by 2032 due to increasing advancements in diagnostic techniques and the expansion of screening panels in the region.

Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., GE Healthcare, Masimo Corporation, Medtronic plc, Natus Medical Incorporated, PerkinElmer, Inc., Thermo Fisher Scientific Inc., Trivitron Healthcare, and Waters Corporation, are some of the major newborn screening companies worldwide.